Cellomatics will be attending the ELRIG CRISPR in Drug Discovery 2022 event in-person at Babraham Research Campus, Cambridge on March 1-2.
Titled ‘From Targets to Therapeutics’, the meeting will focus on the application of genome engineering in identification of novel drug targets through large scale CRISPR based functional genomics studies.
The meeting will be attended by scientists across academia, pharma, biotech and CRO’s.
You can find out more, and register for the event, here.
